CIK 0000771856 · Non-accelerated filer<br>Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521401755
- Phone
- 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-18 | Mendelson Daniel Newman Director | Option exercise | +10,000 | $5.46 | $55K | 103,121 |
| 2020-02-18 | Mendelson Daniel Newman Director | Option exercise | +10,000 | $1.59 | $16K | 113,121 |
| 2020-02-18 | Mendelson Daniel Newman Director | Option exercise | +10,000 | $3.21 | $32K | 123,121 |
| 2020-02-18 | Mendelson Daniel Newman Director | Option exercise · Option to purchase Common Stock | −10,000 | $5.46 | $55K | 0 |
| 2020-02-18 | Mendelson Daniel Newman Director | Option exercise · Option to purchase Common Stock | −10,000 | $1.59 | $16K | 0 |
| 2020-02-18 | Mendelson Daniel Newman Director | Option exercise · Option to purchase Common Stock | −10,000 | $3.21 | $32K | 0 |
| 2020-02-11 | Mendelson Daniel Newman Director | Option exercise | +34,375 | $5.76 | $198K | 103,121 |
| 2020-02-11 | Mendelson Daniel Newman Director | Option exercise · Warrant to purchase shares of Common Stock | −34,375 | $5.76 | $198K | 0 |
| 2019-12-02 | ACKERMAN JOEL Director | Option exercise | +201,590 | $2.10 | $423K | 1,315,467 |
| 2019-12-02 | ACKERMAN JOEL Director | Option exercise | +1,521 | $2.10 | $3K | 1,316,988 |
| 2019-12-02 | ACKERMAN JOEL Director | Option exercise · Option to purchase Common Stock | −201,590 | $2.10 | $423K | 0 |
| 2019-12-02 | ACKERMAN JOEL Director | Option exercise · Option to purchase Common Stock | −1,521 | $2.10 | $3K | 0 |
| 2019-11-04 | Mendelson Daniel Newman Director | Grant or award · Option to purchase Common Stock | +10,000 | $5.43 | $54K | 10,000 |
| 2019-11-04 | SIDRANSKY DAVID Director | Grant or award · Option to purchase Common Stock | +8,333 | $5.43 | $45K | 8,333 |
| 2019-11-04 | Breitfeld Philip P. Director | Grant or award · Option to purchase Common Stock | +8,333 | $5.43 | $45K | 8,333 |
| 2019-11-04 | Poliakoff Abba David Director | Grant or award · Option to purchase Common Stock | +10,000 | $5.43 | $54K | 10,000 |
| 2019-11-04 | ACKERMAN JOEL Director | Grant or award · Option to purchase Common Stock | +16,667 | $5.43 | $91K | 16,667 |
| 2019-11-04 | TOBIN SCOTT R Director | Grant or award · Option to purchase Common Stock | +10,000 | $5.43 | $54K | 10,000 |
| 2019-01-18 | Battery Ventures IX, L.P. 10% owner | Option exercise · Warrant to purchase shares of Common Stock | +58,333 | 0 | ||
| 2019-01-16 | Morris Ronnie CEO | Option exercise | +4,167 | $4.80 | $20K | 837,168 |
Page 8 of 20 · 398 trades